Evidence map›Paper›PMID 41599271›Full record

ArticleMolecules (Basel, Switzerland)2026

Huisgen Cycloaddition of Azidoazulenes: Synthesis, Structural and Optical Properties of 2- and 6-(1,2,3-Triazol-1-yl)azulenes.

Taku Shoji, Miku Yoshida, Masayuki Iwabuchi, Mitsuki Furuhata, Shigeki Mori, Tetsuo Okujima, Ikumi Uchiyama, Ryuta Sekiguchi, Shunji Ito

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Synthesis of azulene fluorophores reveals structure-property relationships.Organic chemistry frontiers : an international journal of organic chemistry · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Taku ShojiDepartment of Chemical Biology and Applied Chemistry, College of Engineering, Nihon University, Koriyama 963-8642, Fukushima, Japan.ORCID 0000-0001-8176-2389
Miku YoshidaDepartment of Chemical Biology and Applied Chemistry, College of Engineering, Nihon University, Koriyama 963-8642, Fukushima, Japan.
Masayuki IwabuchiDepartment of Chemical Biology and Applied Chemistry, College of Engineering, Nihon University, Koriyama 963-8642, Fukushima, Japan.
Mitsuki FuruhataDepartment of Chemical Biology and Applied Chemistry, College of Engineering, Nihon University, Koriyama 963-8642, Fukushima, Japan.
Shigeki MoriAdvanced Research Support Center, Ehime University, Matsuyama 790-8577, Ehime, Japan.ORCID 0000-0001-6731-2357
Tetsuo OkujimaGraduate School of Science and Engineering, Ehime University, Matsuyama 790-8577, Ehime, Japan.ORCID 0000-0002-6552-2606
Ikumi UchiyamaGraduate School of Science and Technology, Hirosaki University, Hirosaki 036-8561, Aomori, Japan.
Ryuta SekiguchiGraduate School of Science and Technology, Hirosaki University, Hirosaki 036-8561, Aomori, Japan.
Shunji ItoGraduate School of Science and Technology, Hirosaki University, Hirosaki 036-8561, Aomori, Japan.ORCID 0000-0002-1627-2583

Funding

Japan Society for the Promotion of Science 21K05037Japan Society for the Promotion of Science 25K08627
6 · The paper itself

Abstract

We developed an efficient and modular route to 2- and 6-(1,2,3-triazol-1-yl)azulenes to expand the synthetic accessibility and functional scope of azulene-based π-systems with stimulus-responsive photophysics. Readily accessible 2- and 6-azidoazulenes, prepared in excellent yields via S

Indexed as

azidoazuleneHuisgen [3 + 2] cycloadditionsingle crystal X-ray analysistriazole

Identifiers

PMID41599271
PMCPMC12843792

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.